India Lockdown: Early Signs of Manufacturing Strains But Resolutions Underway

Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government machinery are actively engaged and working together to ensure that disruptions are minimized in the ‘pharmacy of the world.’  

India_Lockdown
Lockdown Impacts Indian Pharma Manufacturing • Source: Shutterstock

Manufacturing activity in the "pharmacy of the world" appears to be under some early strain following the announcement of a lock-down in India to contain the spread of COVID-19 disease, though the government and industry are believed to be working in tandem and on overtime to ensure that no major crisis is precipitated.

Prime Minister Narendra Modi on 24 March announced a 21-day lock-down in the country effective that midnight, underscoring that even...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip